Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Japan Equity Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Japan Equity FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaHDFC
NAV₹28.1719₹23.6750
NAV date20 Nov 202620 Nov 2026
History12.2 years3.1 years
Expense ratio1.5%1.1%
Stars★★★★★★★★★★
Growth Score67.1094.50

Returns

Nippon India Japan Equity FundHDFC Pharma and Healthcare Fund
1 month−10.56%+12.97%
3 months−10.60%+7.13%
6 months−7.14%+17.84%
YTD+11.43%+33.73%
1 year+16.40%+32.20%
3 years (CAGR)+16.58%+30.70%
5 years (CAGR)+8.37%—
10 years (CAGR)+10.12%—
Since launch+8.89%+31.83%

Risk

Nippon India Japan Equity FundHDFC Pharma and Healthcare Fund
Volatility14.5%15.8%
Downside volatility9.5%8.5%
Sharpe0.691.53
Sortino1.062.86
Calmar1.052.06
Return / risk1.141.95
Deepest fall−29.91%−14.91%
Days to recover500126
Below its high−13.87%+0.00%

Against benchmark

Nippon India Japan Equity FundHDFC Pharma and Healthcare Fund
Alpha+8.74%+7.54%
Beta0.150.97
R²2.6%85.0%
Up capture51.5%108.9%
Down capture−8.1%71.0%
Tracking error19.9%6.1%
Information ratio0.211.17
Treynor0.640.24

Consistency

Nippon India Japan Equity FundHDFC Pharma and Healthcare Fund
Best 1-year+58.70%+67.01%
Middle 1-year+12.04%+23.25%
Worst 1-year−26.91%+1.71%
1-year periods with a loss21.1%0.0%
Middle 3-year+8.38%+30.22%
Positive months66.7%72.2%
Best day+7.06%+3.18%
Worst day−7.02%−3.61%
Worst 5% day−1.68%−1.51%
Positive days52.0%58.3%
NAVs a year229247

SIP of ₹10,000 a month

Nippon India Japan Equity FundHDFC Pharma and Healthcare Fund
5-year XIRR+13.98%—
5-year value₹8,57,545—
3-year XIRR+14.02%+27.71%
1-year XIRR−2.24%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth